Mark Fletcher, EVP & General Counsel at GENEREX BIOTECHNOLOGY CORP (GNBT), bought 25,000 shares at $0.37 ($9K) on 2008-10-31, disclosed to the SEC on 2008-11-03.
Open-market purchase of $9k GNBT by EVP & General Counsel. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.37 | 500 | $185 | 1.9% |
| 2 | $0.38 | 24,500 | $9K | 98.1% |
| Total | $0.38 avg | 25,000 | $9K | 100% |
| Filing → |
| GNBT | BUY | 2009-11-16 | $5K | — | Filing → |
| GNBT | BUY | 2009-01-12 | $4K | — | Filing → |
| GNBT | SELL | 2008-04-21 | $263K | — | Filing → |